13F-HR filed by M28 Capital Management LP
M28 Capital Management LP filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-13, with 13 holding rows worth $108,762,000.
- Accession
- 0000902664-22-002899
- Filer
- CIK 1807489
- Filed
- 2022-05-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2022
A holdings report, 13 entries on the cover page, a total value of $108,762,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $108,762,000 with VALUE read as thousands by filing date, 13F file number 028-21846. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INVIVYD INC | 00534A102 | COMMON STOCK | 6,398,250 | $29,176,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 5,850,000 | $11,700,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 715,880 | $11,354,000 | thousands by filing date | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 527,150 | $11,097,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 4,243,293 | $10,099,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 1,047,900 | $9,966,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 82,900 | $6,816,000 | thousands by filing date | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 466,200 | $4,732,000 | thousands by filing date | |
| LEAP THERAPEUTICS INC | 52187K101 | COM | 2,664,400 | $4,663,000 | thousands by filing date | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 178,500 | $4,073,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 389,353 | $3,617,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 1,001,800 | $907,000 | thousands by filing date | |
| NEXIMMUNE INC | 65344D109 | COM | 133,442 | $562,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000902664-22-002899 | this filing | 2022-05-13 | acceptance time not in the bulk data set |